论文信息 - Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations - 字舞流文

Combined MEK/MDM2 inhibition demonstrates antitumor efficacy in TP53 wild-type thyroid and colorectal cancers with MAPK alterations

Jing Wang | J. Roth | F. Meric-Bernstam | S. Kopetz | M. Ha | V. Holla | B. Fang | Ming Zhao | C. Tapia | Xiaofeng Zheng | A. Akcakanat | Huiqin Chen | N. Busaidy | K. Evans | E. Dumbrava | Kurt W. Evans | S. Pairawan | Yasmeen Q. Rizvi | Y. Rizvi | Vijaykumar Holla